Annual Current Liabilities
$4.87 M
+$3.25 M+202.17%
31 December 2023
Summary:
Yield10 Bioscience annual total current liabilities is currently $4.87 million, with the most recent change of +$3.25 million (+202.17%) on 31 December 2023. During the last 3 years, it has risen by +$3.05 million (+168.19%). YTEN annual current liabilities is now -32.10% below its all-time high of $7.17 million, reached on 31 December 2011.YTEN Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$7.67 M
+$1.46 M+23.49%
30 June 2024
Summary:
Yield10 Bioscience quarterly total current liabilities is currently $7.67 million, with the most recent change of +$1.46 million (+23.49%) on 30 June 2024. Over the past year, it has increased by +$3.72 million (+94.00%). YTEN quarterly current liabilities is now at all-time high.YTEN Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
YTEN Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +202.2% | +94.0% |
| 3 y3 years | +168.2% | +360.3% |
| 5 y5 years | +196.5% | +337.2% |
YTEN Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +202.2% | at high | +457.3% |
| 5 y | 5 years | at high | +202.2% | at high | +457.3% |
| alltime | all time | -32.1% | +202.2% | at high | +457.3% |
Yield10 Bioscience Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $7.67 M(+23.5%) |
| Mar 2024 | - | $6.21 M(+27.6%) |
| Dec 2023 | $4.87 M(+202.2%) | $4.87 M(+23.1%) |
| Sept 2023 | - | $3.95 M(+60.0%) |
| June 2023 | - | $2.47 M(+8.8%) |
| Mar 2023 | - | $2.27 M(+41.0%) |
| Dec 2022 | $1.61 M(-7.1%) | $1.61 M(-11.8%) |
| Sept 2022 | - | $1.83 M(+12.2%) |
| June 2022 | - | $1.63 M(+18.2%) |
| Mar 2022 | - | $1.38 M(-20.6%) |
| Dec 2021 | $1.73 M(-4.5%) | $1.73 M(+4.0%) |
| Sept 2021 | - | $1.67 M(-8.6%) |
| June 2021 | - | $1.82 M(+28.3%) |
| Mar 2021 | - | $1.42 M(-21.7%) |
| Dec 2020 | $1.81 M(-17.8%) | $1.81 M(+22.9%) |
| Sept 2020 | - | $1.48 M(+1.0%) |
| June 2020 | - | $1.46 M(-33.2%) |
| Mar 2020 | - | $2.19 M(-0.9%) |
| Dec 2019 | $2.21 M(+34.5%) | $2.21 M(+25.8%) |
| Sept 2019 | - | $1.75 M(+16.5%) |
| June 2019 | - | $1.51 M(+0.3%) |
| Mar 2019 | - | $1.50 M(-8.5%) |
| Dec 2018 | $1.64 M(-30.9%) | $1.64 M(-9.3%) |
| Sept 2018 | - | $1.81 M(+21.5%) |
| June 2018 | - | $1.49 M(+4.0%) |
| Mar 2018 | - | $1.43 M(-39.7%) |
| Dec 2017 | $2.38 M(-13.9%) | $2.38 M(+19.6%) |
| Sept 2017 | - | $1.99 M(-28.0%) |
| June 2017 | - | $2.76 M(+6.6%) |
| Mar 2017 | - | $2.59 M(-6.2%) |
| Dec 2016 | $2.76 M(-29.5%) | $2.76 M(-7.4%) |
| Sept 2016 | - | $2.98 M(-26.5%) |
| June 2016 | - | $4.05 M(+30.6%) |
| Mar 2016 | - | $3.10 M(-20.7%) |
| Dec 2015 | $3.91 M(-6.7%) | $3.91 M(-6.7%) |
| Sept 2015 | - | $4.19 M(+9.9%) |
| June 2015 | - | $3.81 M(+19.6%) |
| Mar 2015 | - | $3.19 M(-23.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | $4.19 M(-32.4%) | $4.19 M(-1.4%) |
| Sept 2014 | - | $4.25 M(-2.6%) |
| June 2014 | - | $4.36 M(+11.7%) |
| Mar 2014 | - | $3.90 M(-37.0%) |
| Dec 2013 | $6.20 M(+3.5%) | $6.20 M(+44.1%) |
| Sept 2013 | - | $4.30 M(+8.0%) |
| June 2013 | - | $3.98 M(+1.8%) |
| Mar 2013 | - | $3.91 M(-34.7%) |
| Dec 2012 | $5.98 M(-16.5%) | $5.98 M(+23.3%) |
| Sept 2012 | - | $4.85 M(+21.3%) |
| June 2012 | - | $4.00 M(+21.0%) |
| Mar 2012 | - | $3.31 M(-53.9%) |
| Dec 2011 | $7.17 M(+12.0%) | $7.17 M(+3.0%) |
| Sept 2011 | - | $6.96 M(+11.8%) |
| June 2011 | - | $6.22 M(+26.4%) |
| Mar 2011 | - | $4.92 M(-23.0%) |
| Dec 2010 | $6.39 M(+40.2%) | $6.39 M(-9.5%) |
| Sept 2010 | - | $7.07 M(+37.1%) |
| June 2010 | - | $5.16 M(+70.8%) |
| Mar 2010 | - | $3.02 M(-33.8%) |
| Dec 2009 | $4.56 M(-1.0%) | $4.56 M(+8.3%) |
| Sept 2009 | - | $4.21 M(+2.0%) |
| June 2009 | - | $4.13 M(+3.4%) |
| Mar 2009 | - | $3.99 M(-13.4%) |
| Dec 2008 | $4.61 M(-1.1%) | $4.61 M(-4.6%) |
| Sept 2008 | - | $4.83 M(+18.0%) |
| June 2008 | - | $4.09 M(+6.8%) |
| Mar 2008 | - | $3.83 M(-17.7%) |
| Dec 2007 | $4.66 M(+44.6%) | $4.66 M(-12.5%) |
| Sept 2007 | - | $5.32 M(+20.3%) |
| June 2007 | - | $4.42 M(+36.7%) |
| Mar 2007 | - | $3.24 M(+0.5%) |
| Dec 2006 | $3.22 M(+8.3%) | $3.22 M(+17.9%) |
| Sept 2006 | - | $2.73 M(-5.9%) |
| June 2006 | - | $2.90 M(+15.2%) |
| Mar 2006 | - | $2.52 M(-15.2%) |
| Dec 2005 | $2.97 M(+5.9%) | $2.97 M(+5.9%) |
| Dec 2004 | $2.81 M | $2.81 M |
FAQ
- What is Yield10 Bioscience annual total current liabilities?
- What is the all time high annual current liabilities for Yield10 Bioscience?
- What is Yield10 Bioscience annual current liabilities year-on-year change?
- What is Yield10 Bioscience quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Yield10 Bioscience?
- What is Yield10 Bioscience quarterly current liabilities year-on-year change?
What is Yield10 Bioscience annual total current liabilities?
The current annual current liabilities of YTEN is $4.87 M
What is the all time high annual current liabilities for Yield10 Bioscience?
Yield10 Bioscience all-time high annual total current liabilities is $7.17 M
What is Yield10 Bioscience annual current liabilities year-on-year change?
Over the past year, YTEN annual total current liabilities has changed by +$3.25 M (+202.17%)
What is Yield10 Bioscience quarterly total current liabilities?
The current quarterly current liabilities of YTEN is $7.67 M
What is the all time high quarterly current liabilities for Yield10 Bioscience?
Yield10 Bioscience all-time high quarterly total current liabilities is $7.67 M
What is Yield10 Bioscience quarterly current liabilities year-on-year change?
Over the past year, YTEN quarterly total current liabilities has changed by +$3.72 M (+94.00%)